PLAY PODCASTS
Drug Discovery in the Synapse - Derek Small
Episode 475

Drug Discovery in the Synapse - Derek Small

Talking Biotech with Dr. Kevin Folta · Colabra

September 13, 202542m 48s

Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode of the Talking Biotech podcast, Dr. Kevin Folta interviews Derek Small, co-founder and CEO of Syndeoo, focusing on the increasing prevalence of neurological disorders and the challenges in developing effective therapies. They discuss the importance of synaptic function in mental health and neurodegenerative diseases, the innovative Boost platform for drug development, and the potential of event-driven pharmacology. The conversation highlights the hope for new treatments in the pipeline for conditions like depression and Alzheimer's disease.

Topics

neurological disordersmental healthsynaptic functiondrug developmentAlzheimer's diseasedepressionevent-driven pharmacologytherapeutic approachessynaptopathySyndeo